Related content

Second-line docetaxel and gemcitabine combination chemotherapy in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: A phase II trial

By Tas Faruk   Demir Cumhur   Camlica Hakan   Ustuner Zeki   Topuz Erkan  

Medical Oncology, Vol. 21, Iss. 3, 2004-09 ,pp. : 233-240

Humana Press, Inc

Access to resources Recommend Favorite

Erratum to: Evaluation of S-1 as third- or further-line chemotherapy in advanced non-small-cell lung cancer

By Ono Akira   Naito Tateaki   Murakami Haruyasu   Takahashi Toshiaki   Nakamura Yukiko   Tsuya Asuka   Kaira Kyoichi   Igawa Satoshi   Shukuya Takehito   Tamiya Akihiro   Kaira Rieko   Endo Masahiro   Yamamoto Nobuyuki  

International Journal of Clinical Oncology, Vol. 15, Iss. 3, 2010-06 ,pp. : 331-331

Springer Publishing Company

Access to resources Recommend Favorite

Front-line paclitaxel and topotecan chemotherapy in advanced or metastatic non-small-cell lung cancer: a phase II trial

By Stathopoulos G. P.   Katis C.   Tsavdaridis D.   Dimitroulis J.   Karaindros D.   Stathopoulos J.   Dimou E.  

Cancer Chemotherapy and Pharmacology, Vol. 58, Iss. 4, 2006-10 ,pp. : 555-560

Springer Publishing Company

Access to resources Recommend Favorite

Multiple myeloma emerging after chemotherapy for non-small-cell lung cancer

By Marinopoulos Spyridon   Skorda Lamprini   Karatapanis Stylianos   Rasidakis Antonis  

Medical Oncology, Vol. 25, Iss. 4, 2008-12 ,pp. : 415-418

Humana Press, Inc

Access to resources Recommend Favorite

Chemotherapy: still an essential player in non-small-cell lung cancer treatment?

By Ferreira Carlos Gil   Montella Tatiane Caldas   Baldotto Clarissa Seródio   Domingues Pedro Masson  

Lung Cancer Management, Vol. 2, Iss. 5, 2013-10 ,pp. : 381-390

Future Medicine

Access to resources Recommend Favorite